4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-18-033067
Chief Executive Officer gave up 123,333 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil Chief Executive Officer | 2018-05-05 | Shares withheld for taxes | −123,333 | $4.41 | $543,899 | 1,266,063 | D |
Loading xslF345X03/doc4.xml…